“…Doxorubicin is antibiotic from tetracyclin class which widely used in treating various types of cancer such as breast, pulmonary, prostate, servics, and bone cancer (Li, et al, 2014), however treatment with doxorubicin for long term reveals several side effects including cardiotoxicity, hepatotoxicity, nephrotoxicity and immunosupression (Burridge, et al, 2016;Chaudhary, et al, 2016;Mohebbati, et al, 2016). Doxorubicin suppress the immune system by decreasing the expression level of IL-2, production of the γ-interferon, natural killer (NK) cells, proliferation of lymphocytes, and rasio CD4+/CD8+ (Zhang, et al, 2005a).…”